Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
General Electric's 'Cash Gusher' Will Lift Shares: Analyst
The company's financial arm could pay $27 billion in dividends.
The 5 Dumbest Things on Wall Street: Feb. 17
Apple's China Troubles; MSG's Lin-sanity; Avon Gets Dinged; Energy Conversion Convulsion; Yahoo! Channels Charlie.
Watch for a bank ratings cut to damper 2012 share gains of the largest U.S. banks. The Next Big Thing in Biotech: Vivus, Chelsea
Senior columnist Adam Feuerstein explains why Vivus and Chelsea Therapeutics are the next big things in biotech. Gilead Suffers First Hep C Drug Setback
Gilead's GS-7977 fails to cure hard-to-treat hepatitis C patients, showing the wonder drug has flaws. Stocks Mixed as Investors Eye Greek Rescue Package
U.S. stocks were mixed Friday as investors digested greater confidence about a Greek bailout and varied national inflation reads. Can Apple Investors Sue For a Dividend?
Apple had close to $100 billion in cash on its books at the end of the first quarter. Do investors have a legal right to it? 15 Hot, Highly Rated Technology Stocks of 2012 (Update 1)
These are proven gainers with a measure of safety. Wells Fargo Is a Less Risky Bank of America
Philip van Doorn
In contrast to Bank of America's recent downgrade parade, Sterne Agee analyst Todd Hagerman on Friday raised his earnings estimate and price target for Wells Fargo, saying investors could see "an upside earnings surprise in 2012."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV